Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Tumor DNA in Cancer Management: A Value Proposition.

The journal of applied laboratory medicine - 1 Sept 2020

Lam Wai Kei Jacky

Abstract excerpt

BACKGROUND: Analysis of circulating tumor DNA (ctDNA) allows the noninvasive molecular profiling of tumor, and such analysis has gained popularity for the detection of mutations with therapeutic implications. A value-based assessment would be useful for an objective evaluation of the benefits of ctDNA testing. CONTENT: The value proposition approach was used to evaluate the benefits of implementing ctDNA testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32830269
DOI: 10.1093/jalm/jfaa112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Tumor DNA in Cancer Management: A Value Proposition.PMID 32830269Read ↗

Circulating Tumor DNA in Cancer Management.Semantic proximity Read ↗

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of CancerSemantic proximity Read ↗

Circulating Tumor DNA: Measurement and Clinical UtilitySemantic proximity Read ↗

Is It Time to Expand Our Definition of "Clinical Utility"?Semantic proximity Read ↗

The significance of using liquid biopsy to improve treatment outcomes for metastatic patientsSemantic proximity Read ↗

Plasma PIK3CA Mutation Testing in Advanced Breast Cancer Patients for Personalized Medicine: A Value Proposition.Semantic proximity Read ↗

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis.Semantic proximity Read ↗

Value-based genomicsSemantic proximity Read ↗

Dynamic Analysis of Circulating Tumor DNA to Predict the Prognosis and Monitor the Treatment Response of Patients with Metastatic Triple-negative Breast Cancer: a prospective studySemantic proximity Read ↗

The signature of pharmaceutical sensitivity based on ctDNA mutation in eleven cancers.Semantic proximity Read ↗

Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics.Semantic proximity Read ↗

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.